Navigation Links
As Risperdal Lawsuits Mount, Bernstein Liebhard LLP Comments on New Report Detailing High Rate of Psychotropic Drug Use among California Foster Kids
Date:8/26/2014

New York, New York (PRWEB) August 26, 2014

As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) mount in courts throughout the U.S., Bernstein Liebhard LLP notes the publication a new report that raises troubling questions about the use of psychotropic drugs among children in California’s foster care system. According to The Los Angeles Daily News, 1 in 4 adolescent foster children in the state are currently being treated with power psychiatric drugs like Risperdal. That’s three times the nationwide rate. Among other things, the newspaper’s investigation suggested that these medications are not always prescribed for mental illnesses, but instead are used as a “quick fix” to control children with behavioral issues.*

“This report is worrisome, as it notes that medications like Risperdal can be associated with some serious side effects. In fact, hundreds of Risperdal lawsuits are currently pending in courts throughout the country that allege the drug caused patients – many of them children – to suffer serious complications, including excessive growth of male breast tissue,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia (male breast growth) due to their use of Risperdal.

Risperdal Gynecomastia Allegations
Risperdal is currently approved for the treatment of adult and adolescent schizophrenia, as well as bipolar disorder in adults and children ages 10-to-17. The drug’s approved uses also include irritability in children (5-to-16 years of age) with autistic disorder. However, recent research also suggests that off- label use of Risperdal to treat ADHD is also on the rise.**

Currently, some 700 Risperdal lawsuits are pending in U.S. courts, including hundreds that allege the medication caused gynecomastia in men and boys. Court documents indicate that a large number of these claims are moving forward in a mass tort litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing cases. Among other things, the complaints accuse Johnson & Johnson and Janssen Pharmaceuticals of concealing the association between Risperdal and male breast growth, and of improperly marketing the drug for off-label use in children. (In Re: Risperdal Litigation, Case Number 100300296).

Last November, the U.S. Department of Justice announced that Johnson & Johnson and Janssen had agreed to pay $2.2 billion to resolve criminal and civil charges stemming from their marketing of Risperdal and other drugs. Among other things, federal prosecutors had alleged that the companies marketed Risperdal for pediatric uses long before it was approved for such indications in 2006. According to court documents filed in the case, the Justice Department had also accused the companies of concealing Risperdal side effects, including an association with elevated levels of prolactin, a hormone which is linked to the excessive growth of male breast tissue. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who developed gynecomastia allegedly associated with Risperdal may be entitled to file their own legal claim against Johnson & Johnson and Janssen. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.

*dailynews.com/health/20140823/children-in-californias-foster-care-system-are-prescribed-risky-medications, Los Angeles Daily news, August 23, 2014
**health.usnews.com/health-news/news/articles/2012/08/07/more-kids-taking-antipsychotics-for-adhd-study, U.S. News & World Report, August 7, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
info (at) consumerinjurylawyers (dot) com
http://www.risperdallawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/risperdal-lawsuit/risperdal-male-breasts/prweb12122154.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
2. The Consumer Justice Foundation Launches RisperdalLaw.com, an Informational Web Site Dealing with Alleged Risperdal Side Effects Including Gynecomastia
3. Bernstein Liebhard LLP Investigating Risperdal Lawsuits on Behalf of Victims of Male Breast Growth Allegedly Caused by Risperdal
4. New Risperdal Lawsuit Filed in Pennsylvania Litigation; Alleges Male Breast Growth Injuries Caused by Anti-Psychotic Medication, Bernstein Liebhard LLP Reports
5. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Settlement in Risperdal Marketing Investigation
6. Risperdal Lawsuits: $2.2 Billion Settlement Between Federal Government, Johnson & Johnson Over Alleged Illegal Marketing of Risperdal, Other Medications
7. Risperdal Lawsuit News: Johnson & Johnson To Pay Over $2.2 Billion In Risperdal and Invega Settlement Draws Comment From Wright & Schulte LLC
8. J&J to Pay $2.2B to Settle Allegations Over Its Marketing of Risperdal; Parker Waichman LLP Applauds Efforts of Whistleblowers in Helping Compel Resolution
9. Risperdal Lawsuit News: Rottenstein Law Group LLP Comments on $2 Billion Risperdal Settlement Report
10. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Mounting Claims Involving Risperdal Gynecomastia Allegations in Pennsylvania Litigation
11. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Release of Emails from Johnson & Johnson’s Janssen Subsidiary in Federal Risperdal Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... Buffalo, NY (PRWEB) , ... August 15, 2017 , ... ... as maintenance treatment for multiple myeloma has been completed, with the team’s findings now ... Philip L. McCarthy, MD , Director of the Blood and Marrow Transplant Program at ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... Goodwill CEO, John McCain said, “We are overwhelmed with gratitude for the very ... for people who need assistance to both get a job and keep it. ...
(Date:8/15/2017)... CA (PRWEB) , ... August 15, 2017 , ... ... research charity, is proud to announce the 19th Annual V Foundation Wine Celebration ... This year’s total included more than $7 million in “Fund-A-Need” donations to support ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... Snap-on Smile® consultations. Patients interested in orthodontics, dental crowns and teeth whitening ... Nash provides Snap-on Smile treatment at his state-of-the-art practice, Nash Family Dentistry, in ...
(Date:8/15/2017)... ... 2017 , ... Organizers today announced plans and unveiled the website for ... and activations held during UN General Assembly week and focused on driving progress toward ... Goals Week will be held 16-23 September, with events and activations taking place in ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... Medical Aesthetics, a leading medical aesthetic clinic in Singapore ... several skin conditions from the inside. The natural process ... The skin becomes more transparent due to the thinning of the ... from the sun contributes to aging skin, causing age spots and ... ...
(Date:7/26/2017)... The Galien Foundation announced today the 2017 11 ... Award Nominees. Counted among the global health innovation industry,s most ... technology product achievement that improves the human condition. ... be U.S. Food and Drug Administration (FDA) approved for market ... impact human health. Sales data are not considered by the ...
(Date:7/25/2017)... 2017  Debbie,s Dream Foundation: Curing Stomach Cancer (DDF) is excited to host ... at the Bonaventure Resort & Spa in Weston, Florida ... Luncheon ... Zelman, and Luncheon Committee Co-chair Sabrina Kurzman. ... Aura Morales-Guzman, Angela Perez, DDF Board ...
Breaking Medicine Technology: